158 related articles for article (PubMed ID: 21261775)
1. Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors.
Antonelli M; Hasselblatt M; Haberler C; Di Giannatale A; Garrè ML; Donofrio V; Lauriola L; Ridola V; Arcella A; Frühwald M; Giangaspero F
Brain Pathol; 2011 Sep; 21(5):558-63. PubMed ID: 21261775
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
4. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors.
Birks DK; Kleinschmidt-DeMasters BK; Donson AM; Barton VN; McNatt SA; Foreman NK; Handler MH
Brain Pathol; 2010 Jan; 20(1):140-50. PubMed ID: 19220299
[TBL] [Abstract][Full Text] [Related]
5. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.
Kleinschmidt-DeMasters BK; Alassiri AH; Birks DK; Newell KL; Moore W; Lillehei KO
Am J Surg Pathol; 2010 Mar; 34(3):341-54. PubMed ID: 20118769
[TBL] [Abstract][Full Text] [Related]
6. Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors.
Sullivan LM; Yankovich T; Le P; Martinez D; Santi M; Biegel JA; Pawel BR; Judkins AR
Am J Surg Pathol; 2012 Jan; 36(1):73-80. PubMed ID: 21989342
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
8. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
9. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
Miller S; Ward JH; Rogers HA; Lowe J; Grundy RG
Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
[TBL] [Abstract][Full Text] [Related]
10. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
12. Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases.
Makuria AT; Rushing EJ; McGrail KM; Hartmann DP; Azumi N; Ozdemirli M
J Neurooncol; 2008 Jul; 88(3):321-30. PubMed ID: 18369529
[TBL] [Abstract][Full Text] [Related]
13. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
14. Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.
McLendon RE; Adekunle A; Rajaram V; Koçak M; Blaney SM
Arch Pathol Lab Med; 2011 Aug; 135(8):984-93. PubMed ID: 21809989
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
16. Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China.
Wang RF; Guan WB; Yan Y; Jiang B; Ma J; Jiang MW; Wang LF
Pathology; 2016 Oct; 48(6):555-63. PubMed ID: 27558890
[TBL] [Abstract][Full Text] [Related]
17. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
[TBL] [Abstract][Full Text] [Related]
19. Adult Atypical Teratoid/Rhabdoid Tumors.
Wu WW; Bi WL; Kang YJ; Ramkissoon SH; Prasad S; Shih HA; Reardon DA; Dunn IF
World Neurosurg; 2016 Jan; 85():197-204. PubMed ID: 26344637
[TBL] [Abstract][Full Text] [Related]
20. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
